AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 204 filers reported holding AMICUS THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $19,576,000 | -0.6% | 1,875,105 | +2.3% | 0.75% | -4.5% |
| Q2 2022 | $19,691,000 | +20.9% | 1,833,446 | +6.6% | 0.78% | +44.7% |
| Q1 2022 | $16,284,000 | -17.6% | 1,719,577 | +0.5% | 0.54% | -8.6% |
| Q4 2021 | $19,770,000 | +20.7% | 1,711,710 | -0.2% | 0.59% | +17.0% |
| Q3 2021 | $16,376,000 | -4.7% | 1,714,731 | -3.8% | 0.51% | -1.0% |
| Q2 2021 | $17,175,000 | +2.7% | 1,781,625 | +5.3% | 0.51% | -5.0% |
| Q1 2021 | $16,719,000 | -67.1% | 1,692,241 | -23.2% | 0.54% | -68.1% |
| Q4 2020 | $50,894,000 | +91.3% | 2,204,140 | +17.0% | 1.68% | +45.9% |
| Q3 2020 | $26,604,000 | -4.2% | 1,884,144 | +2.3% | 1.16% | -7.2% |
| Q2 2020 | $27,768,000 | +46.8% | 1,841,376 | -10.0% | 1.24% | +15.2% |
| Q1 2020 | $18,912,000 | +51.5% | 2,046,778 | +59.7% | 1.08% | +100.6% |
| Q4 2019 | $12,482,000 | – | 1,281,553 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,114,043 | $116,817,000 | 7.46% |
| Parametrica Management Ltd | 597,279 | $6,899,000 | 6.86% |
| Redmile Group, LLC | 22,716,086 | $262,371,000 | 5.96% |
| Perceptive Advisors | 53,118,886 | $613,524,000 | 4.73% |
| Asymmetry Capital Management, L.P. | 716,709 | $8,278,000 | 4.39% |
| CM Management, LLC | 450,000 | $5,198,000 | 3.93% |
| Avoro Capital Advisors LLC | 18,500,000 | $213,675,000 | 3.64% |
| Kynam Capital Management, LP | 573,699 | $6,626,000 | 3.54% |
| SECTORAL ASSET MANAGEMENT INC | 1,242,882 | $14,355,000 | 2.16% |
| Ghost Tree Capital, LLC | 500,000 | $5,775,000 | 2.07% |